Ciliatech News & Updates

Follow Ciliatech’s past history and latest exciting developments via the news stories below.

Mandy Robinson Profile Pic

I am delighted to announce the appointment of Mandy Robinson to the position of Senior Surgical Glaucoma Sales Specialist, UK & Ireland reporting to myself in our growing commercial organisation. Mandy brings with her a truly robust track record with 20 years of success in surgical ophthalmic training and sales,

Eleticia Szozda

We are thrilled to formally announce the appointment of Eleticia Szozda (Ele’) to the position of Global Surgical Training Consultant to support the surgical training efforts for Intercil® during both the early (‘soft’) commercialisation in Europe, and eventually supporting Global surgical training requirements for clinical trials In the first phase

Denise Cole

We are delighted to announce the appointment of Denise Cole to the position of Surgical Glaucoma Specialist, UK & Ireland. Denise brings deep surgical experience from the Operating Room (OR) joining us most recently from Arthrex UK where she was Clinical Specialist in Orthopaedic Surgery. Denise’s thriving family life has

Andrew Tatham In Surgery

Ciliatech were delighted to join Mr. Andrew Tatham in his operating room (OR) as he performed the first ever Intercil® Uveal Spacer implantation in the UK following the recent EU MDR CE Mark approval of the product. Mr. Tatham has previously commented: “The supraciliary space offers a viable and advantageous

Karsten Klabe First Surgeries

Just weeks after confirming EU MDR CE Mark approval for our novel Intercil Uveal Spacer, Ciliatech are thrilled to announce that Dr. Karsten Klabe becomes the first ever surgeon in the world to have implanted Intercil® at his specialist eye surgery centre in Dusseldorf, Germany. Dr. Klabe commented: “It is

Intercil Uveal Spacer Obtains CE Mark

Ciliatech obtains CE mark for eye implant Intercil® Uveal Spacer, novel treatment for patients with glaucoma Innovative implant that lowers IOP without penetrating anterior chamber set to be game changer in surgical treatment of both open and narrow angle glaucoma CE mark pivotal step in paving way for Intercil’s commercial

Ciliatech is delighted to announce the appointment of Coen Van Der Steur to the newly created position of International Business Development Consultant, reporting directly to our Commercial Operations team as part of our growing global organisation. Coen brings with him an outstanding 34-year track record in the industry, including significant

Gabi Grubert Profile Pic

Ciliatech is delighted to announce the appointment of Gabriele (‘Gabi’) Grubert to the position of Senior Surgical Glaucoma Sales Specialist for the DACH region, as part of our expanding commercial organisation. Gabi brings with her an impressive 33-year career in surgical ophthalmic sales, with particular expertise in Minimally Invasive Glaucoma

Exploring a novel class of glaucoma surgery that targets the supraciliary space. BY ANDREW J. TATHAM, MD, MBA MIGS has transformed glaucoma care by enabling earlier surgical intervention, improved IOP control, and reduced dependence on long-term medical therapy. Although MIGS procedures that target the trabecular meshwork (TM) and Schlemm canal

Published by Eye News, the longest-standing magazine dedicated to ophthalmology in the UK. Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Chavanod (near Annecy), France, November 12,

Intercil is a surgically implantable medical device that is indicated in adult patients (18 years old and older) suffering from mild to moderate glaucoma. Intercil is intended for use only by trained ophthalmic surgeons. The device is not exempt from the usual risks of surgery.

This site is only for the use of professionals associated with the field of Ophthalmology and is not intended for patients.